Prolongation of corneal xenograft survival with deoxyspergualin and anti-LFA-1 monoclonal antibody.
Yamagami
S
S
Department of Ophthalmology, Jichi Medical School, Tochigi, Japan.
Isobe
M
M
Yamagami
H
H
Hori
J
J
Kaburaki
T
T
Tsuru
T
T
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D016039:Corneal Transplantation / Q000276:immunology* / Q000473:pathology; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016169:Lymphocyte Function-Associated Antigen-1 / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D051381:Rats; D011917:Rats, Inbred Lew; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000473:pathology
D000911:Antibodies, Monoclonal; D006146:Guanidines; D007166:Immunosuppressive Agents; D016169:Lymphocyte Function-Associated Antigen-1; C037258:gusperimus